First human test for new cough pill
NCT ID NCT07161180
Summary
This is an early safety study for a new pill called PBK_M2301, which combines two ingredients for cough. It aims to see how the drug moves through the body and if it's safe. Researchers will give the pill to 32 healthy adults and compare it to two separate reference drugs. The main goal is to measure drug levels in the blood and check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H+ Yangji Hospital
RECRUITINGSeoul, Seoul, 08799, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.